Skip to content

Study on PK-PD and TDM of Levofloxicin

Study on PK-PD and TDM of Levofloxicin - Study on PK-PD & TDM of LVFX

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000014457
Enrollment
70
Registered
2014-07-02
Start date
2014-08-11
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infectious disease

Interventions

None listed

Sponsors

Division of TDM, Kitasato Institute Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Inpatients treated with levofloxicin.

Exclusion criteria

Exclusion criteria: Nothing

Design outcomes

Primary

MeasureTime frame
Ratio of 24h-AUC to MIC and clinical laboratory data and findings related to infection

Countries

Japan

Contacts

Public ContactKimikazu Shinozaki

Kitasato Institute Hospital Division of TDM

shinozakik@pharm.kitasato-u.ac.jp03-5791-6232

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026